---

A giant ovarian tumor in perimenopausal women: A case report and review of literature

---

Case Report

Author Details : Anju Kumari Rani*, Jyotsna Pandey, Deepa Kapoor

Volume : 9, Issue : 2, Year : 2022

Article Page : 288-291

https://doi.org/10.18231/j.ijogr.2022.053

Suggest article by email

Get Permission

---

Abstract

Aim: To remind clinicians of the challenges in diagnosis management, and precautions to be taken when performing surgery for giant ovarian tumor.
Case: Our reported case is a 50-year old multiparous perimenopausal woman presented with marked progressive abdominal distension, difficulty in breathing and amenorrhea at the gynaecology OPD General Hospital, Sanjay Gandhi Postgraduate Institute of Medical Sciences Lucknow. The tumor was removed by laparotomy without any spill and her peroperative and Postoperative periods were uneventful.
Materials and Methods: The details were collected by history-taking, clinical examination, laboratory investigations, abdominal ultrasonography, CECT abdomen and by histopathological study of the excised surgical specimen.
Results: The case was reported as a huge mucinous cystadenoma of ovary with good surgical outcome.
Conclusions: Such huge ovarian tumor is rare now a days because of awareness and accessibility to better imaging modalities. These tumors are potentially dangerous in its massive form if not timely diagnosed and managed. They have excellent surgical results and survival rates.
Key message: Early detection of ovarian tumor is the key to success.
 

Keywords: Ovarian tumor, Perimenopausal women.

How to cite : Rani A K, Pandey J, Kapoor D, A giant ovarian tumor in perimenopausal women: A case report and review of literature. Indian J Obstet Gynecol Res 2022;9(2):288-291

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.